BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3792769)

  • 1. Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity.
    Edwards RL; Levine JB; Green R; Duffy M; Mathews E; Brande W; Rickles FR
    Gastroenterology; 1987 Feb; 92(2):329-37. PubMed ID: 3792769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes.
    Griga T; Werner S; Köller M; Tromm A; May B
    Dig Dis Sci; 1999 Jun; 44(6):1196-201. PubMed ID: 10389696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for activation of coagulation in Crohn's disease.
    Hudson M; Hutton RA; Wakefield AJ; Sawyerr AM; Pounder RE
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):773-8. PubMed ID: 1489898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte procoagulant activity in breast cancer.
    Auger MJ; Mackie MJ
    Thromb Res; 1987 Jul; 47(1):77-84. PubMed ID: 3660345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinopeptide A reactive peptides and procoagulant activity in bronchoalveolar lavage: relationship to rheumatoid interstitial lung disease.
    Idell S; Garcia JG; Gonzalez K; McLarty J; Fair DS
    J Rheumatol; 1989 May; 16(5):592-8. PubMed ID: 2666653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostasis in Crohn's disease: low factor XIII levels in active disease.
    Wisén O; Gardlund B
    Scand J Gastroenterol; 1988 Oct; 23(8):961-6. PubMed ID: 3201134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients.
    Morgan D; Edwards RL; Rickles FR
    Haemostasis; 1988; 18(1):55-65. PubMed ID: 3047024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation.
    Edwards RL; Rickles FR; Cronlund M
    J Lab Clin Med; 1981 Dec; 98(6):917-28. PubMed ID: 7310230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological manifestations of a prethrombotic state in developmental Crohn's disease].
    Chamouard P; Grunebaum L; Duclos B; Wiesel L; Cazenave JP
    Gastroenterol Clin Biol; 1990; 14(3):203-8. PubMed ID: 2188861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
    Roy MS; Podgor MJ; Rick ME
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence of activated blood coagulation in Crohn's disease.
    Novacek G; Kapiotis S; Moser G; Speiser W; Gangl A; Vogelsang H
    Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):963-7. PubMed ID: 9391785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease.
    Griga T; Klein W; Epplen JT; Hebler U; Stachon A; May B
    Hepatogastroenterology; 2005; 52(63):808-11. PubMed ID: 15966209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between tissue factor activity and tissue factor expression in endotoxin-induced monocytes is associated with apoptosis and necrosis.
    Henriksson CE; Klingenberg O; Ovstebø R; Joø GB; Westvik AB; Kierulf P
    Thromb Haemost; 2005 Dec; 94(6):1236-44. PubMed ID: 16411400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes.
    Osterud B; Due J
    Scand J Haematol; 1984 Mar; 32(3):258-64. PubMed ID: 6199833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of measuring blood coagulation factor XIIIA regularly and continuously in patients with Crohn's disease.
    Higaki S; Nakano K; Onaka S; Amano A; Tanioka Y; Harada K; Hashimoto S; Sakaida I; Okita K
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1407-11. PubMed ID: 16911684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced generation of monocyte tissue factor and increased plasma prothrombin fragment1+2 levels in patients with polycythemia vera: mechanism of activation of blood coagulation.
    Kornberg A; Rahimi-Levene N; Yona R; Mor A; Rachmilewitz EA
    Am J Hematol; 1997 Sep; 56(1):5-11. PubMed ID: 9298860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor exposing microparticles in inflammatory bowel disease.
    Palkovits J; Novacek G; Kollars M; Hron G; Osterode W; Quehenberger P; Kyrle PA; Vogelsang H; Reinisch W; Papay P; Weltermann A
    J Crohns Colitis; 2013 Apr; 7(3):222-9. PubMed ID: 22705067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.